Skip to main content
Lupin Ltd logo

Lupin Ltd — Investor Relations & Filings

Ticker · LUPIN ISIN · INE326A01037 LEI · 335800HHXTESDEE2FC65 BSE.NS Manufacturing
Open in API
Filings indexed 3,174 across all filing types
Latest filing 2024-07-04 Declaration of Voting R…
Country IN India
Listing BSE.NS LUPIN

About Lupin Ltd

https://www.lupin.com/

Lupin Ltd is a global pharmaceutical organization specializing in the development, manufacturing, and marketing of a comprehensive range of generic and branded formulations, biotechnology products, and active pharmaceutical ingredients. The company holds a significant market position in therapeutic segments such as cardiovascular, diabetology, asthma, pediatrics, gastrointestinal, anti-infectives, and non-steroidal anti-inflammatory drugs. It is notably recognized for its leadership in the anti-tuberculosis medication sector. With a strong emphasis on research and development, Lupin focuses on complex generics, specialty medicines, and biosimilars. The company operates advanced manufacturing facilities and maintains a substantial commercial presence across major global markets, including North America, Europe, and the Asia-Pacific region, delivering affordable and high-quality healthcare solutions.

Recent filings

Filing Released Lang Actions
Record Date
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a formal letter addressed to stock exchanges and shareholders regarding the Annual General Meeting (AGM) of Lupin Limited. It details the date and mode of the AGM (through video conferencing), the record date for dividend payment, and the procedures for remote e-voting. It references compliance with SEBI and MCA circulars related to conducting AGMs and voting. The document does not contain financial statements or detailed financial analysis but rather provides logistical and procedural information about the AGM and voting process. It also mentions that the notice of the AGM will be issued in due course, indicating this is a preparatory or informational communication rather than the AGM materials themselves. The document length is 7052 characters, which is relatively short and consistent with an announcement or notice rather than a full report. Therefore, this document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA) or possibly AGM Information (AGM-R). However, since it primarily focuses on the voting process, record dates, and e-voting details rather than the AGM presentation materials, it aligns best with Declaration of Voting Results & Voting Rights Announcements (DVA).
2024-07-04 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a compliance certificate under Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015. It details the loss of share certificates for a shareholder and is addressed to stock exchanges. The content is a regulatory compliance communication rather than a financial report or announcement of voting results, management changes, or capital changes. It is a formal regulatory filing related to share certificate loss reporting. The document length is short (2862 characters) and it does not contain financial data or report content. Therefore, it fits best under Regulatory Filings (RNS).
2024-07-03 English
Intimation regarding loss of share certificate by the shareholder.
Regulatory Filings Classification · 95% confidence The document is a compliance certificate under Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015. It details the loss of share certificates for a shareholder and is addressed to stock exchanges. The document is short (2870 characters) and serves as a regulatory compliance communication rather than a financial report or announcement of voting results, management changes, or capital changes. It is not an annual report, earnings release, or any form of financial statement. It is also not a report publication announcement since it contains the actual compliance information. This type of document fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory compliance documents that do not fit other specific categories.
2024-07-03 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a compliance certificate under Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, regarding the loss of share certificates. It is addressed to stock exchanges and signed by the company secretary. The content is a regulatory compliance communication about shareholder share certificate loss, not a financial report, earnings release, or management information. It does not contain financial data or detailed report content but is a formal regulatory filing. Therefore, it fits best under Regulatory Filings (RNS). The document length is short and it is a certificate type filing, not a report or announcement of a report.
2024-07-02 English
Intimation regarding loss of share certificate by the shareholder.
Regulatory Filings Classification · 95% confidence The document is a compliance certificate under Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015. It details the loss of share certificates reported by shareholders. The document is addressed to stock exchanges and signed by the company secretary. It is a regulatory compliance filing related to share certificate loss, not a financial report, earnings release, or management information. It does not contain financial data or report results but is a regulatory disclosure. Therefore, it fits best under Regulatory Filings (RNS). The document length is short (2854 characters), and it is a formal compliance certificate, not an announcement or report publication.
2024-07-02 English
Today i.e., July 1, 2024, Lupin Limited completed the transfer of its trade generics business in India to Lupin Life Sciences Limited, wholly owned subsidiary of the Company, as a going ....
Regulatory Filings Classification · 95% confidence The document is a short disclosure letter addressed to stock exchanges regarding the completion of a business transfer transaction under Regulation 30 of SEBI Listing Obligations and Disclosure Requirements. It informs about the completion of a slump sale transaction but does not contain financial statements, detailed financial analysis, or any report content. The document length is only 1936 characters, which is quite short and consistent with an announcement rather than a full report. It is a regulatory disclosure about a corporate event, fitting the category of Regulatory Filings (RNS) as it does not fit into more specific categories like M&A filings or capital updates that require more detailed documentation. Therefore, the appropriate classification is Regulatory Filings (RNS).
2024-07-01 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.